Search details
1.
Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-ß signaling pathway.
Proc Natl Acad Sci U S A
; 118(33)2021 08 17.
Article
in English
| MEDLINE | ID: mdl-34385332
2.
Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A.
Proc Natl Acad Sci U S A
; 117(49): 30907-30917, 2020 12 08.
Article
in English
| MEDLINE | ID: mdl-33219121
3.
Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight.
Proc Natl Acad Sci U S A
; 117(38): 23942-23951, 2020 09 22.
Article
in English
| MEDLINE | ID: mdl-32900939
4.
Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.
Curr Osteoporos Rep
; 20(1): 78-89, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35226254
5.
Management of pseudohypoparathyroidism.
Curr Opin Pediatr
; 31(4): 537-549, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31145125
6.
Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
J Biol Chem
; 292(33): 13809-13822, 2017 08 18.
Article
in English
| MEDLINE | ID: mdl-28659341
7.
Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.
Curr Diab Rep
; 16(10): 91, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27525682
8.
Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care.
Pediatr Res
; 79(3): 489-95, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26539664
9.
Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development.
PLoS One
; 18(1): e0280463, 2023.
Article
in English
| MEDLINE | ID: mdl-36662765
10.
Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy.
JBMR Plus
; 6(1): e10570, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-35079678
11.
Functional replacement of myostatin with GDF-11 in the germline of mice.
Skelet Muscle
; 12(1): 7, 2022 03 15.
Article
in English
| MEDLINE | ID: mdl-35287700
12.
Deletion of Gdf15 Reduces ER Stress-induced Beta-cell Apoptosis and Diabetes.
Endocrinology
; 163(5)2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35290443
13.
Hypercalcemia in children and adolescents.
Curr Opin Pediatr
; 22(4): 508-15, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20601885
14.
Treatment of rickets and dyslipidemia in twins with progressive familial intrahepatic cholestasis type 2.
Int J Pediatr Endocrinol
; 2020: 9, 2020.
Article
in English
| MEDLINE | ID: mdl-32508937
15.
Legg-Calve-Perthes disease in an 8-year old girl with Acrodysostosis type 1 on growth hormone therapy: case report.
Int J Pediatr Endocrinol
; 2020: 15, 2020.
Article
in English
| MEDLINE | ID: mdl-32782451
16.
Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.
Horm Res Paediatr
; 93(3): 182-196, 2020.
Article
in English
| MEDLINE | ID: mdl-32756064
17.
Central hypothyroidism and Sturge-Weber syndrome.
Pediatr Neurol
; 39(1): 58-62, 2008 Jul.
Article
in English
| MEDLINE | ID: mdl-18555176
18.
Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMI.
J Clin Endocrinol Metab
; 103(1): 158-168, 2018 01 01.
Article
in English
| MEDLINE | ID: mdl-29059381
19.
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.
Nat Rev Endocrinol
; 14(8): 476-500, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29959430
20.
Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity.
J Clin Endocrinol Metab
; 92(3): 1073-9, 2007 Mar.
Article
in English
| MEDLINE | ID: mdl-17164301